Bayesian sample size for exploratory clinical trials incorporating historical data

被引:37
|
作者
Whitehead, John [1 ]
Valdes-Marquez, Elsa [2 ]
Johnson, Patrick [3 ]
Graham, Gordon [3 ]
机构
[1] Univ Lancaster, Fylde Coll, Dept Math & Stat, MPS Res Unit, Lancaster LA1 4YE, England
[2] Univ Reading, Sect Quantitat Biol & Appl Stat, Reading, Berks, England
[3] Pfizer Global Res & Dev, Sandwich, Kent, England
关键词
Bayesian methods; clinical trial; phase II trial; proof-of-concept study; sample size; score statistic;
D O I
10.1002/sim.3140
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This paper presents a simple Bayesian approach to sample size determination in clinical trials. It is required that the trial should be large enough to ensure that the data collected will provide convincing evidence either that an experimental treatment is better than a control or that it fails to improve upon control by some clinically relevant difference. The method resembles standard frequentist formulations of the problem, and indeed in certain circumstances involving 'non-informative' prior information it leads to identical answers. In particular, unlike many Bayesian approaches to sample size determination, use is made of an alternative hypothesis that an experimental treatment is better than a control treatment by some specified magnitude. The approach is introduced in the context of testing whether a single stream of binary observations are consistent with a given success rate p(0). Next the case of comparing two independent streams of normally distributed responses is considered, first under the assumption that their common variance is known and then for unknown variance. Finally, the more general situation in which a large sample is to be collected and analysed according to the asymptotic properties of the score statistic is explored. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:2307 / 2327
页数:21
相关论文
共 50 条
  • [1] Blinded sample size recalculation in clinical trials incorporating historical data
    Hees, Katharina
    Kieser, Meinhard
    [J]. CONTEMPORARY CLINICAL TRIALS, 2017, 63 : 2 - 7
  • [2] A Bayesian predictive sample size selection design for single-arm exploratory clinical trials
    Teramukai, Satoshi
    Daimon, Takashi
    Zohar, Sarah
    [J]. STATISTICS IN MEDICINE, 2012, 31 (30) : 4243 - 4254
  • [3] Using historical data for Bayesian sample size determination
    De Santis, Fulvio
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2007, 170 : 95 - 113
  • [4] Robust Bayesian sample size determination in clinical trials
    Brutti, Pierpaolo
    De Santis, Fulvio
    Gubbiotti, Stefania
    [J]. STATISTICS IN MEDICINE, 2008, 27 (13) : 2290 - 2306
  • [5] A Bayesian approach for incorporating economic factors in sample size design for clinical trials of individual drugs and portfolios of drugs
    Patel, Nitin R.
    Ankolekar, Suresh
    [J]. STATISTICS IN MEDICINE, 2007, 26 (27) : 4976 - 4988
  • [6] Bayesian sample size determination for phase IIA clinical trials using historical data and semi-parametric prior's elicitation
    Berchialla, Paola
    Zohar, Sarah
    Baldi, Ileana
    [J]. PHARMACEUTICAL STATISTICS, 2019, 18 (02) : 198 - 211
  • [7] Incorporating historical control data into the design and analysis of clinical trials
    Bennett, Maxine
    Powley, William
    Wetherington, Jeffrey
    Mander, Adrian
    [J]. TRIALS, 2015, 16
  • [8] Incorporating historical control data into the design and analysis of clinical trials
    Maxine Bennett
    William Powley
    Jeffrey Wetherington
    Adrian Mander
    [J]. Trials, 16
  • [9] Bayesian probability of success for clinical trials using historical data
    Ibrahim, Joseph G.
    Chen, Ming-Hui
    Lakshminarayanan, Mani
    Liu, Guanghan F.
    Heyse, Joseph F.
    [J]. STATISTICS IN MEDICINE, 2015, 34 (02) : 249 - 264
  • [10] Bayesian assessment of sample size for clinical trials of cost-effectiveness
    O'Hagan, A
    Stevens, JW
    [J]. MEDICAL DECISION MAKING, 2001, 21 (03) : 219 - 230